Pablo Cironi

Director/Board Member at

Minoryx Therapeutics SL

Health Technology

Consumer Services

Commercial Services

Profile

Pablo Cironi is currently the Director of Life Science Investment at Caixa Capital Risc SGEIC SA, Director at Medlumics SL, Director at Minoryx Therapeutics SL, Director at Aelix Therapeutics SL, Director at GlyCardial Diagnostics SL, and Director at Iproteos SL.
He previously worked as a Director at Sanifit Therapeutics SA, AptaTargets SL, SpliceBio SL, Technology Development Manager at Fundación Botín, and Head of the Technology & Business Dev Office at Centre For Genomic Regulation.
Dr. Cironi holds a doctorate degree from the University of Barcelona in 2004, a graduate degree from Universidad de Buenos Aires in 2000, and a doctorate degree from Harvard Medical School in 2009.

Pablo Cironi active positions

Companies	Position	Start
Minoryx Therapeutics SL Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products	Director/Board Member	01/07/2019
Medlumics SL Medlumics SL Medical SpecialtiesHealth Technology Provides medical imaging diagnostics services	Director/Board Member	01/02/2019
Aelix Therapeutics SL Aelix Therapeutics SL BiotechnologyHealth Technology Develops novel vaccines to cure HIV infection	Director/Board Member	01/07/2019
Iproteos SL Iproteos SL Miscellaneous Commercial ServicesCommercial Services Engages in research and development for schizophrenia treatment	Director/Board Member	-
GlyCardial Diagnostics SL GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology	Director/Board Member	01/08/2019
Caixa Capital Risc SGEIC SA Caixa Capital Risc SGEIC SA Investment ManagersFinance Caixa Capital Risc invests in startup companies located in Europe and North America, primarily in Spain and Portugal. The firm focuses on information technology, life sciences, and industrial technologies sector. It provides equity and loan financing for early and growth stage transactions. It acts as a lead investor and is open to co-invest with other general partners	Private Equity Investor	01/09/2018

All active positions of Pablo Cironi

Former positions of Pablo Cironi

Companies	Position	End
SpliceBio SL SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology	Director/Board Member	01/01/2022
Sanifit Therapeutics SA Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders	Director/Board Member	01/01/2022
AptaTargets SL AptaTargets SL Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses in developing therapeutic applications based on aptamer technology	Director/Board Member	01/09/2020
░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░

See the detail of Pablo Cironi's experience

Training of Pablo Cironi

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pablo Cironi's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
University of Barcelona University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Universidad de Buenos Aires Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Caixa Capital Risc SGEIC SA Caixa Capital Risc SGEIC SA Investment ManagersFinance Caixa Capital Risc invests in startup companies located in Europe and North America, primarily in Spain and Portugal. The firm focuses on information technology, life sciences, and industrial technologies sector. It provides equity and loan financing for early and growth stage transactions. It acts as a lead investor and is open to co-invest with other general partners	Finance
Sanifit Therapeutics SA Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Medlumics SL Medlumics SL Medical SpecialtiesHealth Technology Provides medical imaging diagnostics services	Health Technology
Minoryx Therapeutics SL Minoryx Therapeutics SL BiotechnologyHealth Technology Develops pharmaceutical products	Health Technology
Fundación Botín
Aelix Therapeutics SL Aelix Therapeutics SL BiotechnologyHealth Technology Develops novel vaccines to cure HIV infection	Health Technology
Iproteos SL Iproteos SL Miscellaneous Commercial ServicesCommercial Services Engages in research and development for schizophrenia treatment	Commercial Services
AptaTargets SL AptaTargets SL Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses in developing therapeutic applications based on aptamer technology	Health Technology
GlyCardial Diagnostics SL GlyCardial Diagnostics SL Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology	Commercial Services
SpliceBio SL SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology	Health Technology
Centre For Genomic Regulation